Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial

British Journal of Dermatology(2024)10.1093/bjd/ljae063Source: DataRank Database

Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial is a research paper published in British Journal of Dermatology (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 3.30)OA: greenTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Michelle Hao,Andrew Kwong,Brandon Levian ORCID,Jon Cogan ORCID,Yingping Hou ORCID

Live enrichment

PubMed:38366625 PMC:PMC11250489 OpenAlex:https://openalex.org/W4391897894

Epidermolysis Bullosa Medical Research Foundation

Directed Medical Research Program

VA Merit Award

Epidermolysis Bullosa Research Partnership

NIH HHS

National Institutes of Health

NIH HHS

Epidermolysis Bullosa Research Partnership

Epidermolysis Bullosa Medical Research Foundation

Directed Medical Research Program

VA Merit Award

FWCI

3.30

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11250489/pdf/ljae063.pdf

publisherhttps://academic.oup.com/bjd/advance-article-pdf/doi/10.1093/bjd/ljae063/57096995/ljae063.pdf

publisherhttps://academic.oup.com/bjd/article-pdf/191/2/267/58554294/ljae063.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11250489

Fields of Study

Skin and Cellular Biology ResearchProteoglycans and glycosaminoglycans researchAutoimmune Bullous Skin DiseasesMedicineHumansGentamicinsEpidermolysis Bullosa DystrophicaCollagen Type VIIPilot ProjectsMaleFemaleCodon, NonsenseAdultAdolescentTreatment OutcomeYoung AdultWound HealingSkinAnti-Bacterial AgentsDrug Administration Schedule

MeSH Terms

AdolescentAdultAnti-Bacterial AgentsDrug Administration ScheduleFemaleGentamicinsHumansMalePilot ProjectsSkinWound HealingEpidermolysis Bullosa DystrophicaTreatment OutcomeCodon, NonsenseCollagen Type VIIYoung Adult

Keywords

Anchoring fibrilsEpidermolysis bullosaDermatologyMedicineGenetic enhancementGentamicinJunctional epidermolysis bullosa (veterinary medicine)Type I collagenPathologyGeneMutationBiologyGeneticsAntibioticsUltrastructure

Sustainable Development Goals

SDG 0: Good health and well-being